Clinical Trial: The Research of Ammoxetine Hydrochloride Enteric-coated Tablets in Subjects With Depression

U.S., Feb. 15 -- ClinicalTrials.gov registry received information related to the study (NCT06827431) titled 'The Research of Ammoxetine Hydrochloride Enteric-coated Tablets in Subjects With Depression' on Dec. 30, 2024.

Brief Summary: The purpose of this study is to evaluate the efficacy and safety of Ammoxetine hydrochloride enteric-coated tablets in subjects with depression.

Study Start Date: Feb. 14

Study Type: INTERVENTIONAL

Condition: Major Depressive Disorder (MDD)

Intervention: DRUG: Ammoxetine

Drug: Ammoxetine Ammoxetine hydrochloride enteric-coated tablets Drug: Placebo placebo to Ammoxetine and Sertraline.

DRUG: Ammoxetine

Drug: Ammoxetine Ammoxetine hydrochloride enteric-coated tablets Drug: Placebo placebo to Sertralin...